Literature DB >> 15502862

Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers.

Sabine Colnot1, Michiko Niwa-Kawakita, Ghislaine Hamard, Cécile Godard, Servane Le Plenier, Christophe Houbron, Béatrice Romagnolo, Dominique Berrebi, Marco Giovannini, Christine Perret.   

Abstract

Murine models of familial adenomatous polyposis harbor a germinal heterozygous mutation on Apc tumor suppressor gene. They are valuable tools for studying intestinal carcinogenesis, as most human sporadic cancers contain inactivating mutations of APC. However, Apc(+/-) mice, such as the well-characterized Apc(Min/+) model, develop cancers principally in the small intestine, while humans develop mainly colorectal cancers. We used a Cre-loxP strategy to achieve a new model of germline Apc invalidation in which exon 14 is deleted. We compared the phenotype of these Apc(Delta14/+) mice to that of the classical Apc(Min/+). The main phenotypic difference is the shift of the tumors in the distal colon and rectum, often associated with a rectal prolapse. Thus, the severity of the colorectal phenotype is partly due to the particular mutation Delta14, but also to environmental parameters, as mice raised in conventional conditions developed more colon cancers than those raised in pathogen-free conditions. All lesions, including early lesions, revealed Apc LOH and loss of Apc gene expression. They accumulated beta-catenin, overexpressed the beta-catenin target genes cyclin D1 and c-Myc, and the distribution pattern of glutamine synthetase, a beta-catenin target gene recently identified in the liver, was mosaic in intestinal adenomas. The Apc(Delta14/+) model is thus a useful new tool for studies on the molecular mechanisms of colorectal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15502862     DOI: 10.1038/labinvest.3700180

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  71 in total

1.  Genetic and Chemical Models of Colorectal Cancer in Mice.

Authors:  Mandayam O Nandan; Vincent W Yang
Journal:  Curr Colorectal Cancer Rep       Date:  2010-03-10

Review 2.  Colorectal cancer models for novel drug discovery.

Authors:  Daniel Golovko; Dmitriy Kedrin; Ömer H Yilmaz; Jatin Roper
Journal:  Expert Opin Drug Discov       Date:  2015-08-21       Impact factor: 6.098

3.  Regulation of VDR Expression in Apc-Mutant Mice, Human Colon Cancers and Adenomas.

Authors:  Charles Giardina; Masako Nakanishi; Awaad Khan; Anton Kuratnik; Wanli Xu; Bruce Brenner; Daniel W Rosenberg
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-14

4.  Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signaling.

Authors:  Caroline Bonnans; Maud Flacelière; Fanny Grillet; Christelle Dantec; Jean-Pierre Desvignes; Julie Pannequin; Dany Severac; Emeric Dubois; Frédéric Bibeau; Virginie Escriou; Philippe Crespy; Laurent Journot; Frédéric Hollande; Dominique Joubert
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

5.  Adenomatous polyposis coli (APC) is essential for maintaining the integrity of the seminiferous epithelium.

Authors:  Pradeep S Tanwar; Lihua Zhang; Jose M Teixeira
Journal:  Mol Endocrinol       Date:  2011-08-04

Review 6.  Novel translational strategies in colorectal cancer research.

Authors:  Ignacio Gil-Bazo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

7.  Fine-tuning and autoregulation of the intestinal determinant and tumor suppressor homeobox gene CDX2 by alternative splicing.

Authors:  Camille Balbinot; Marie Vanier; Olivier Armant; Asmaa Nair; Julien Penichon; Christine Soret; Elisabeth Martin; Thoueiba Saandi; Jean-Marie Reimund; Jacqueline Deschamps; Felix Beck; Claire Domon-Dell; Isabelle Gross; Isabelle Duluc; Jean-Noël Freund
Journal:  Cell Death Differ       Date:  2017-09-01       Impact factor: 15.828

Review 8.  Understanding phenotypic variation in rodent models with germline Apc mutations.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Cancer Res       Date:  2013-04-11       Impact factor: 12.701

9.  Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase.

Authors:  Ehud Zigmond; Ami Ben Ya'acov; Hyunbeom Lee; Yoav Lichtenstein; Zvi Shalev; Yoav Smith; Lidya Zolotarov; Ehud Ziv; Rony Kalman; Hoang V Le; Hejun Lu; Richard B Silverman; Yaron Ilan
Journal:  ACS Med Chem Lett       Date:  2015-05-29       Impact factor: 4.345

10.  Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice.

Authors:  Charlotte Labalette; Yann Nouët; Florence Levillayer; Sabine Colnot; Ju Chen; Valere Claude; Michel Huerre; Christine Perret; Marie-Annick Buendia; Yu Wei
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.